
Bromotheophylline
CAS No. 10381-75-6
Bromotheophylline( 8-BROMOTHEOPHYLLINE )
Catalog No. M22265 CAS No. 10381-75-6
Bromotheophylline is the active moiety of pamabrom, a mixture of 2-amino-2-methyl-propanol and bromotheophylline.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
500MG | 45 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBromotheophylline
-
NoteResearch use only, not for human use.
-
Brief DescriptionBromotheophylline is the active moiety of pamabrom, a mixture of 2-amino-2-methyl-propanol and bromotheophylline.
-
DescriptionBromotheophylline is the active moiety of pamabrom, a mixture of 2-amino-2-methyl-propanol and bromotheophylline. From this mixture, bromotheophylline acts as a weak diuretic that has been used along with some analgesics to relieve the symptoms of premenstrual syndrome.
-
In Vitro——
-
In Vivo——
-
Synonyms8-BROMOTHEOPHYLLINE
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number10381-75-6
-
Formula Weight259.06
-
Molecular FormulaC7H7BrN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (96.50 mM)
-
SMILESCn2c(=O)n(C)c1nc([Br])nc1c2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Arundic Acid
Arundic Acid is an astrocyte-modulating agent, delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis.
-
Prohydrojasmon
Prohydrojasmon is a synthesized plant gowth regulator which has jasmonic acid activity.
-
Pseudo RACK1
Activator of protein kinase C; attached to cell permeabilization Antennapedia domain vector peptide. Consists of peptide derived from the C2 domain of PKC β linked by a disulfide bridge to the Antennapedia domain vector peptide. The Antennapedia peptide is actively taken up by intact cells, at 4 or 37°C, ensuring rapid and effective uptake of the activator peptide. Once inside the cell, the disulfide bonds are subjected to reduction in the cytoplasm leading to release of the activator peptide.